Kyverna Therapeutics, Inc. (KYTX)
NASDAQ·Healthcare·Biotechnology
$8.19
+4.07%
Mkt Cap $327.12M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (7 analysts)
$30.75
Range $25.00 – $33.00
Implied Upside
+275.5%
Consensus $30.75 vs current $8.19
NASDAQ·Healthcare·Biotechnology
$8.19
+4.07%
Mkt Cap $327.12M
Buy
5
Hold
0
Sell
0
Price Target (7 analysts)
$30.75
Range $25.00 – $33.00
+275.5%
Consensus $30.75 vs current $8.19